Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.07
-0.72 (-0.35%)
AAPL  262.38
-1.97 (-0.75%)
AMD  200.27
+0.15 (0.07%)
BAC  52.45
-0.91 (-1.71%)
GOOG  304.86
+0.92 (0.30%)
META  644.60
+1.38 (0.21%)
MSFT  398.22
-1.38 (-0.35%)
NVDA  185.97
-2.01 (-1.07%)
ORCL  157.37
+1.20 (0.77%)
TSLA  409.95
-1.37 (-0.33%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.